lonsurf
les laboratoires servier - trifluridine, tipiracil hydrochloride - colorectal neoplasms - antineoplastic agents - colorectal cancerlonsurf is indicated in combination with bevacizumab for the treatment of adult patients with metastatic colorectal cancer (crc) who have received two prior anticancer treatment regimens including fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapies, anti-vegf agents, and/or anti-egfr agents.lonsurf is indicated as monotherapy for the treatment of adult patients with metastatic colorectal cancer (crc) who have been previously treated with, or are not considered candidates for, available therapies including fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapies, anti-vegf agents, and anti egfr agentsgastric cancerlonsurf is indicated as monotherapy for the treatment of adult patients with metastatic gastric cancer including adenocarcinoma of the gastroesophageal junction, who have been previously treated with at least two prior systemic treatment regimens for advanced disease.
renagel
sanofi b.v. - sevelamer - renal dialysis; hyperphosphatemia - all other therapeutic products - renagel is indicated for the control of hyperphosphataemia in adult patients receiving haemodialysis or peritoneal dialysis.renagel should be used within the context of a multiple therapeutic approach, which could include calcium supplements, 1,25 - dihydroxy vitamin d3 or one of its analogues to control the development of renal bone disease.
mabthera 100mg10ml concentrate for solution for infusion vials
roche products ltd - rituximab - solution for infusion - 10mg/1ml
mabthera 500mg50ml concentrate for solution for infusion vials
roche products ltd - rituximab - solution for infusion - 10mg/1ml
tarceva 100mg tablets
roche products ltd - erlotinib hydrochloride - tablet - 100mg
tarceva 150mg tablets
roche products ltd - erlotinib hydrochloride - tablet - 150mg
tarceva 25mg tablets
roche products ltd - erlotinib hydrochloride - tablet - 25mg
roactemra 200mg10ml concentrate for solution for infusion vials
roche products ltd - tocilizumab - solution for infusion - 20mg/1ml
roactemra 80mg4ml concentrate for solution for infusion vials
roche products ltd - tocilizumab - solution for infusion - 20mg/1ml
roactemra 400mg20ml concentrate for solution for infusion vials
roche products ltd - tocilizumab - solution for infusion - 20mg/1ml